EVALUATION OF DDX3 DEAD BOX RNA HELICASE AS DRUG TARGET AND GENETICALLY MODIFIED LIVE ATTENUATED VACCINE CANDIDATE AGAINST PROTOZOAN PARASITE Leishmania donovani

Abstract

newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced